Comments on: AstraZeneca’s hairy cell leukaemia treatment approved by FDA https://ukinvestormagazine.co.uk/astrazenecas-hairy-cell-leukaemia-treatment-approved-by-fda/ UK Investor Magazine provides breaking financial news and investment ideas Wed, 06 Feb 2019 15:16:51 +0000 hourly 1 https://wordpress.org/?v=6.9.4 By: AstraZeneca treatment for rare disease granted orphan status - UK Investor Magazine https://ukinvestormagazine.co.uk/astrazenecas-hairy-cell-leukaemia-treatment-approved-by-fda/#comment-9477 Wed, 06 Feb 2019 15:16:51 +0000 https://ukinvestormagazine.co.uk/?p=14164#comment-9477 […] last news from the latter portion of 2018 that the pharma juggernaut had developed a series of new cancer treatments, though the company experienced mixed […]

]]> By: AstraZeneca sells rights to Grunenthal - UK Investor Magazine https://ukinvestormagazine.co.uk/astrazenecas-hairy-cell-leukaemia-treatment-approved-by-fda/#comment-8734 Tue, 30 Oct 2018 10:46:04 +0000 https://ukinvestormagazine.co.uk/?p=14164#comment-8734 […] Earlier this year, the European Commission approved AstraZeneca’s Bydureon BCise devise. Equally, its hairy cell leukaemia treatment was approved by the FDA. […]

]]> By: Avacta Group sees increased losses following increase R&D investment - UK Investor Magazine https://ukinvestormagazine.co.uk/astrazenecas-hairy-cell-leukaemia-treatment-approved-by-fda/#comment-8550 Wed, 03 Oct 2018 11:41:26 +0000 https://ukinvestormagazine.co.uk/?p=14164#comment-8550 […] firm stating that they are potentially tapping into a multi-billion dollar market for Affirmers, an alternative for chemotherapy and antibodies that does not rely on killing cancerous […]

]]>